READDI, the Rapidly Emerging Antiviral Drug Development Initiative, has just received a big boost in accomplishing its mission of putting five antiviral drugs “on the shelf” ahead of future pandemics. The National Institutes of Health (NIH) announced Wednesday that READDI … Continued

On May 10-12, 2022,  the Eshelman Institute will be hosting Amazon AWS for a three-day immersion training. The training will focus on Amazon AWS’s data science toolsets and give participants an understanding of Amazon Cloud, SageMaker, AI services, and more. … Continued

In early 2020, the Eshelman Institute for Innovation helped launch the Rapidly Emerging Antiviral Drug Development Initiative (READDI). Since then, READDI has been collaborating with partners across the globe to bring broad-spectrum antiviral drugs through Phase 1 testing to be … Continued

The Eshelman Institute for Innovation is pleased to announce the recipients of their 2021 grant cycle! A total of $2.1 million has been granted to the below seven projects. Since 2015, the Eshelman Institute has brought value to the University … Continued

In 2012, a revolutionary new way to edit genes was unveiled to the world – CRISPR. Since then, the technology has been named as a “Breakthrough of the Year” by Science and has expanded to be applied to targeted epigenome … Continued

As part of the annual Eshelman Institute for Innovation (EII) student and postdoctoral grant process, the EII Rankin Innovator Acceleration Award is given annually to the student(s) with the highest rated, commercially focused proposal. The 2021 recipients of this award are … Continued

The Eshelman Institute for Innovation (EII) is pleased to announce the addition of four new Steering Board members. These individuals represent a broad array of experience in biopharmaceutical/therapeutic innovation, which will build on the talent of the existing Board Members. … Continued

As part of the annual Eshelman Institute for Innovation (EII) student and postdoctoral grant process, the EII Rankin Innovator Acceleration Award is given annually to the student(s) with the highest rated, commercially focused proposal. This year’s recipients include Ph.D. students Sabrina … Continued

The Eshelman Institute for Innovation (EII) is pleased to announce the recipients of its 2020 grant cycle. A total of $1.3M will be granted to the below six projects:   Kevin Frankowski Center for Integrative Chemical Biology and Drug Discovery … Continued

The Structural Genomics Consortium (SGC), the University of North Carolina at Chapel Hill and the Eshelman Institute for Innovation, announce the launch of the Rapidly Emerging Antiviral Drug Discovery Initiative (READDI), to discover and develop drugs to put “on the … Continued